This is a heavily interactive web application, and JavaScript is required. Simple HTML interfaces are possible, but that is not what this is.
Post
Addario Lung Cancer Medical Institute (ALCMI)
alcmi.bsky.social
did:plc:bxzk4m7k4l4pqhhbb3guu3qx
A global Phase 3 trial is underway to test ifinatamab deruxtecan (I-DXd), a B7-H3–directed antibody–drug conjugate, as a potential new standard for relapsed small cell lung cancer (SCLC). #lungcancer
https://www.tandfonline.com/doi/full/10.1080/14796694.2025.2565995#abstract
2025-10-19T14:01:40.061Z